Alliance Global Partners lowered the firm’s price target on Quantum-Si (QSI) to $3.65 from $3.75 and keeps a Buy rating on the shares following the Q4 report. The company targets significant revenue growth in 2025 but there is an “added element of uncertainty” given the potential for lower National Institutes of Health-driven academic lab funding, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QSI:
- Quantum-Si’s Earnings Call: Growth and Strategic Moves
- Cautious Optimism for Quantum-Si Amid Market Position and Funding Uncertainties
- Quantum-Si’s Strategic Growth and Financial Strength Drive Buy Rating
- Quantum-Si Reports Milestone Revenue and Strategic Growth
- Quantum-Si reports Q4 EPS (23c) vs. (16c) last year